New hope for lung cancer patients with tough brain spread
NCT ID NCT07398599
Summary
This study is testing a more intensive treatment for people with advanced lung cancer where the disease has spread to the lining of the brain and spine, and has gotten worse despite standard targeted therapy. About 30 participants will receive a higher dose of their targeted pill, plus two other drugs given into the bloodstream and directly into the spinal fluid. The main goal is to see if this combination can better control the cancer in the brain and spine and to monitor side effects.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for LEPTOMENINGEAL METASTASIS are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
The Second Affiliated Hospital of Nanchang University
RECRUITINGNanchang, Jiangxi, China
Conditions
Explore the condition pages connected to this study.